Fluent Elara THC-CBD Blend Suppositories

(1 customer review)


Balanced THC+CBD BlendElara is a blend of Cannabis sativa and Cannabis indica hybrid strains with an approximate 1:1 ratio of THC:CBD with only mild euphoria. Elara harmoniously blends the top characteristics of each strain into one product. Patients can benefit tremendously from the synergistic effects of THC + CBD in treating various types of medical conditions. Elara also contains a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.

Current medical literature supports the use of CBD+THC rich products for the treatment of all conditions approved for medical cannabis.

CBD Content: Approximately 50%

THC Content: Approximately 50%

THC to CBD Ratio: 1:1

Dosing Units: 30 mg / suppository (~15 mg CBD/suppository; ~15 mg THC/suppository)

Total Doses: 10 suppositories per package

Sold By: Fluent

Categories: Suppositories, CBD THC Balanced 1:1

Leave Your Review: Write A Review

Out of stock

1 review for Fluent Elara THC-CBD Blend Suppositories

  1. Gregory Weeks

    I have been using the Fluent Elara THC-CBD Blend Suppositories after prostate cancer returned to biochemical levels after surgery of >= .20. My PSA dropped to >=.19 in 4 months and then >=.18 in 8 months. Unfortunately, this is the second time that Fluent is out of inventory on this product, not for a short time but for months at a time. I believe that if I would have used this product after surgery and it were more consistently available my cancer would not have returned or at a minimal kept in check. Prior to using the suppositories and when they are not available I used drops and this seemed to slow the progression of the cancer experienced prior to use, only after using suppositories did I see a decrease in PSA.

Add a review

Your email address will not be published. Required fields are marked *

Product Description

Ideal for localized pain, cramps and inflammation with prolonged effects. The absorption rate is very high and like other suppositories, the application puts the medication closer to internal cellular walls so essential cannabinoids enter the bloodstream much more quickly.

Patients are recommended to initiate treatment on the evening of Day 1 with 1 application. Remove suppository from packaging and insert rectally or vaginally. After 1 – 2 hours, patients reassess symptoms.

If symptoms have improved or subsided, no additional applications are needed and patients can apply as needed.

Cash & CanPay Accepted

Elara® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.